NH
Novo Holdings
Private EquityActiveNovo Seeds is a capital investment firm focused on the biotechnology sector that aims to deliver health care applications.
Hellerup, DenmarkFounded 2015
37
Investments
10
Exits
$170B
AUM
27.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Novo Holdings.
Investment Thesis & Strategy
Novo Seeds invests in biotechnology companies at various stages, seeking to fund healthcare applications.
Investment Activity
Deals per year over the last 22 years
1
20000
20010
20020
20030
20040
20053
20060
20070
20080
20090
20100
20110
20120
20131
20141
20150
20161
20170
20180
20190
20204
2021Portfolio Companies
Selected investments from their portfolio of 37 companies
N
Novo Nordisk
Biotech · Growth, 0
N
Nykode Therapeutics
Biotech · Growth, 2021
I
Inversago Pharma
Biotech · Series A, 2021
C
Cellarity
Biotech · Series B, 2021
S
Shape Therapeutics
Biotech · Series A, 2021
X
Xalient
Biotech · Growth, 2017
E
Evotec
Biotech · Growth, 2015
A
Avillion
Biotech · Growth, 2014
S
Symphogen
Biotech · Growth, 2006
A
Ascendis Pharma
Biotech · Growth, 2006
G
Genmab
Biotech · Growth, 2006
C
Copenhagen Capacity
Other · Growth, 2000
Notable Exits
CompanyTypeYearValue / Acquirer
Avida GlobalAcquisition2022—
ShapewaysIPO2021—
Sana BiotechnologyIPO2021—
Ellie MaeAcquisition2019$11B
ConvaTecIPO2016—
Xellia PharmaceuticalsAcquisition2013—
Omega Healthcare InvestorsIPO2003—
ALKIPO2001—
NovozymesIPO2000—
GenmabIPO2000—
Frequently Asked Questions
Novo Holdings focuses on Series B, Series C+ stage investments.